OpenURL Connection Search

Select item for more details and to access through your institution.

Elevated levels of damageassociated molecular patterns HMGB1 and S100A8/A9 coupled with toll-like receptor-triggered monocyte activation are associated with inflammation in patients with myelofibrosis.
Published in:
Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1365015
By:
- De Luca, Geraldine;
- Goette, Nora P.;
- Lev, Paola R.;
- Baroni Pietto, Maria C.;
- Marin Oyarzún, Cecilia P.;
- Castro Rıós, Miguel A.;
- Moiraghi, Beatriz;
- Sackmann, Federico;
- Kamiya, Laureano J.;
- Verri, Veronica;
- Caula, Victoria;
- Fernandez, Vanina;
- Vicente, Angeles;
- Pose Cabarcos, Julio;
- Caruso, Vanesa;
- Camacho, Maria F.;
- Larripa, Irene B.;
- Khoury, Marina;
- Marta, Rosana F.;
- Glembotsky, Ana C.
Publication type:
Article
Neutrophil extracellular trap formation and circulating nucleosomes in patients with chronic myeloproliferative neoplasms.
Published in:
Scientific Reports, 2016, p. 38738, doi. 10.1038/srep38738
By:
- Marin Oyarzún, Cecilia P.;
- Carestia, Agostina;
- Lev, Paola R.;
- Glembotsky, Ana C.;
- Castro Ríos, Miguel A.;
- Moiraghi, Beatriz;
- Molinas, Felisa C.;
- Marta, Rosana F.;
- Schattner, Mirta;
- Heller, Paula G.
Publication type:
Article
Platelet Toll-Like Receptors Mediate Thromboinflammatory Responses in Patients With Essential Thrombocythemia.
Published in:
Frontiers in Immunology, 2020, v. 11, p. 1, doi. 10.3389/fimmu.2020.00705
By:
- Marín Oyarzún, Cecilia P.;
- Glembotsky, Ana C.;
- Goette, Nora P.;
- Lev, Paola R.;
- De Luca, Geraldine;
- Baroni Pietto, María C.;
- Moiraghi, Beatriz;
- Castro Ríos, Miguel A.;
- Vicente, Angeles;
- Marta, Rosana F.;
- Schattner, Mirta;
- Heller, Paula G.
Publication type:
Article
High cell-free DNA is associated with disease progression, inflammasome activation and elevated levels of inflammasome-related cytokine IL-18 in patients with myelofibrosis.
Published in:
Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1161832
By:
- De Luca, Geraldine;
- Lev, Paola R.;
- Camacho, Maria F.;
- Goette, Nora P.;
- Sackmann, Federico;
- Rios, Miguel A. Castro;
- Moiraghi, Beatriz;
- Guerrieri, Veronica Cortes;
- Bendek, Georgina;
- Carricondo, Emiliano;
- Enrico, Alicia;
- Vallejo, Veronica;
- Varela, Ana;
- Khoury, Marina;
- Gutierrez, Marina;
- Larripa, Irene B.;
- Marta, Rosana F.;
- Glembotsky, Ana C.;
- Heller, Paula G.
Publication type:
Article
In-depth characterization of NK cell markers from CML patients who discontinued tyrosine kinase inhibitor therapy.
Published in:
Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1241600
By:
- Sanchez, María Belén;
- Vasconcelos Cordoba, Bianca;
- Pavlovsky, Carolina;
- Moiraghi, Beatriz;
- Varela, Ana;
- Custidiano, Rosario;
- Fernandez, Isolda;
- Freitas, María Josefina;
- Ventriglia, María Verónica;
- Bendek, Georgina;
- Mariano, Romina;
- Mela Osorio, María José;
- Arturo Pavlovsky, Miguel;
- García de Labanca, Ana;
- Foncuberta, Cecilia;
- Giere, Isabel;
- Vera, Masiel;
- Juni, Mariana;
- Mordoh, José;
- Sanchez Avalos, Julio Cesar
Publication type:
Article
Molecular Monitoring of Imatinib in Chronic Myeloid Leukemia Patients in Complete Cytogenetic Remission: Does Achievement of a Stable Major Molecular Response at any Time Point Identify a Privileged Group of Patients? A Multicenter Experience in Argentina and Uruguay
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2011, v. 11, n. 3, p. 280, doi. 10.1016/j.clml.2011.03.016
By:
- Pavlovsky, Carolina;
- Giere, Isabel;
- Moiraghi, Beatriz;
- Pavlovsky, Miguel A.;
- Aranguren, Pedro Negri;
- García, Juan;
- Fernandez, Isolda;
- Bengió, Raquel;
- Milone, Jorge;
- Labanca, Valentin;
- Uriarte, Rosario;
- Lombardi, Virginia;
- Reinoso, Fernanda García;
- Magariños, Alicia E.;
- Martinez, Lem;
- Murro, Héctor;
- Lastiri, Francisco;
- Pavlovsky, Santiago
Publication type:
Article
Long-Term Follow-Up in Patients With Chronic Myeloid Leukemia Treated With Ponatinib in a Real-World Cohort: Safety and Efficacy Analysis.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 3, p. 158, doi. 10.1016/j.clml.2023.10.008
By:
- Osorio, Maria Jose Mela;
- Moiraghi, Beatriz;
- Osycka, Maria Victoria;
- Pavlovsky, Miguel A.;
- Varela, Ana Ines;
- Del Prete, Georgina Emilia Bendek;
- Tosin, Maria Fernanda;
- Perez, Mariel Ana;
- Riva, Maria Elisa;
- Berrios, Roxana Ramirez;
- Fernandez, Isolda;
- Massa, Federico Sackmann;
- Giere, Isabel;
- Sighel, Carolina;
- Pavlovsky, Carolina
Publication type:
Article
CML-129: OPTIC Primary Analysis: A Dose-Optimization Study of 3 Starting Doses of Ponatinib (PON).
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S328, doi. 10.1016/S2152-2650(21)01769-9
By:
- Cortes, Jorge E.;
- Apperley, Jane F.;
- Lomaia, Elza;
- Moiraghi, Beatriz;
- Sutton, Maria Undurraga;
- Pavlovsky, Carolina;
- Chuah, Charles;
- Sacha, Tomasz;
- Lipton, Jeffrey H.;
- McCloskey, James;
- Hochhaus, Andreas;
- Rousselot, Philippe;
- Rosti, Gianantonio;
- De Lavallade, Hugues;
- Mauro, Michael J.;
- Hall, Tracey;
- Lu, Vickie;
- Srivastava, Shouryadeep;
- Deininger, Michael W.
Publication type:
Article
Poster: CML-129: OPTIC Primary Analysis: A Dose-Optimization Study of 3 Starting Doses of Ponatinib (PON).
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S223, doi. 10.1016/S2152-2650(21)01408-7
By:
- Cortes, Jorge E.;
- Apperley, Jane F.;
- Lomaia, Elza;
- Moiraghi, Beatriz;
- Sutton, Maria Undurraga;
- Pavlovsky, Carolina;
- Chuah, Charles;
- Sacha, Tomasz;
- Lipton, Jeffrey H.;
- McCloskey, James;
- Hochhaus, Andreas;
- Rousselot, Philippe;
- Rosti, Gianantonio;
- Lavallade, Hugues De;
- Mauro, Michael J.;
- Hall, Tracey;
- Lu, Vickie;
- Srivastava, Shouryadeep;
- Deininger, Michael W.
Publication type:
Article
Oral Abstract: CML-129: OPTIC Primary Analysis: A Dose-Optimization Study of 3 Starting Doses of Ponatinib (PON).
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S202, doi. 10.1016/S2152-2650(21)01274-X
By:
- Cortes, Jorge E.;
- Apperley, Jane F.;
- Lomaia, Elza;
- Moiraghi, Beatriz;
- Sutton, Maria Undurraga;
- Pavlovsky, Carolina;
- Chuah, Charles;
- Sacha, Tomasz;
- Lipton, Jeffrey H.;
- McCloskey, James;
- Hochhaus, Andreas;
- Rousselot, Philippe;
- Rosti, Gianantonio;
- De Lavallade, Hugues;
- Mauro, Michael J.;
- Hall, Tracey;
- Lu, Vickie;
- Srivastava, Shouryadeep;
- Deininger, Michael W.
Publication type:
Article
ENESTop 192-Weeks Results: Treatment-Free Remission (TFR) in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) After Stopping Second-Line Nilotinib.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S288, doi. 10.1016/j.clml.2019.07.233
By:
- Mahon, Francois-Xavier;
- Boquimpani, Carla;
- Takahashi, Naoto;
- Benyamini, Noam;
- Clementino, Nelma Cristina D.;
- Shuvaev, Vasily;
- Lipton, Jeffrey H.;
- Turkina, Anna G.;
- De Paz Arias, Raquel;
- Moiraghi, Beatriz;
- Nicolini, Franck E.;
- Dengler, Jolanta;
- Sacha, Tomasz;
- Kim, Dong-Wook;
- Fellague-Chebra, Rafik;
- Tiwari, Ranjan;
- Bouard, Catherine;
- Hughes, Timothy P.
Publication type:
Article
ENESTop 144-Week Update: Long-Term Treatment-Free Remission (TFR) in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) After Stopping Second-Line Nilotinib.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S222, doi. 10.1016/j.clml.2018.07.092
By:
- Hughes, Timothy P.;
- Boquimpani, Carla;
- Takahashi, Naoto;
- Benyamini, Noam;
- Clementino, Nelma Cristina D.;
- Shuvaev, Vasily;
- Merchant, Akil;
- Lipton, Jeffrey H.;
- Turkina, Anna G.;
- De Paz Arias, Raquel;
- Moiraghi, Beatriz;
- Nicolini, Franck E.;
- Dengler, Jolanta;
- Sacha, Tomasz;
- Kim, Dong-Wook;
- Fellague-Chebra, Rafik;
- Acharya, Sandip;
- Chaturvedi, Shalini;
- Bouard, Catherine;
- Mahon, François-Xavier
Publication type:
Article
Elevated plasma levels of IL-6 and MCP-1 selectively identify CML patients who better sustain molecular remission after TKI withdrawal.
Published in:
Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01440-6
By:
- Pavlovsky, Carolina;
- Vasconcelos Cordoba, Bianca;
- Sanchez, María Belén;
- Moiraghi, Beatriz;
- Varela, Ana;
- Custidiano, Rosario;
- Fernandez, Isolda;
- Freitas, Maria Josefina;
- Ventriglia, Maria Verónica;
- Bendek, Georgina;
- Mariano, Romina;
- Mela Osorio, María José;
- Pavlovsky, Miguel Angel;
- de Labanca, Ana García;
- Foncuberta, Cecilia;
- Giere, Isabel;
- Vera, Masiel;
- Juni, Mariana;
- Mordoh, Jose;
- Sanchez Avalos, Julio Cesar
Publication type:
Article
Elevated levels of damageassociated molecular patterns HMGB1 and S100A8/A9 coupled with toll-like receptor-triggered monocyte activation are associated with inflammation in patients with myelofibrosis.
Published in:
Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1365015
By:
- De Luca, Geraldine;
- Goette, Nora P.;
- Lev, Paola R.;
- Baroni Pietto, Maria C.;
- Marin Oyarzún, Cecilia P.;
- Castro Ríos, Miguel A.;
- Moiraghi, Beatriz;
- Sackmann, Federico;
- Kamiya, Laureano J.;
- Verri, Veronica;
- Caula, Victoria;
- Fernandez, Vanina;
- Vicente, Angeles;
- Pose Cabarcos, Julio;
- Caruso, Vanesa;
- Camacho, Maria F.;
- Larripa, Irene B.;
- Khoury, Marina;
- Marta, Rosana F.;
- Glembotsky, Ana C.
Publication type:
Article
Elevated levels of damage-associated molecular patterns HMGB1 and S100A8/A9 coupled with toll-like receptor-triggered monocyte activation are associated with inflammation in patients with myelofibrosis.
Published in:
Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1365015
By:
- De Luca, Geraldine;
- Goette, Nora P.;
- Lev, Paola R.;
- Baroni Pietto, Maria C.;
- Marin Oyarzún, Cecilia P.;
- Castro Ríos, Miguel A.;
- Moiraghi, Beatriz;
- Sackmann, Federico;
- Kamiya, Laureano J.;
- Verri, Veronica;
- Caula, Victoria;
- Fernandez, Vanina;
- Vicente, Angeles;
- Pose Cabarcos, Julio;
- Caruso, Vanesa;
- Camacho, Maria F.;
- Larripa, Irene B.;
- Khoury, Marina;
- Marta, Rosana F.;
- Glembotsky, Ana C.
Publication type:
Article
Treatment-Free Remission After Second-Line Nilotinib Treatment in Patients With Chronic Myeloid Leukemia in Chronic Phase: Results From a Single-Group, Phase 2, Open-Label Study.
Published in:
Annals of Internal Medicine, 2018, v. 168, n. 7, p. 461, doi. 10.7326/M17-1094
By:
- Mahon, François-Xavier;
- Boquimpani, Carla;
- Kim, Dong-Wook;
- Benyamini, Noam;
- Clementino, Nelma Cristina D.;
- Shuvaev, Vasily;
- Ailawadhi, Sikander;
- Lipton, Jeffrey Howard;
- Turkina, Anna G.;
- De Paz, Raquel;
- Moiraghi, Beatriz;
- Nicolini, Franck E.;
- Dengler, Jolanta;
- Sacha, Tomasz;
- Takahashi, Naoto;
- Fellague-Chebra, Rafik;
- Acharya, Sandip;
- Wong, Stephane;
- Jin, Yu;
- Hughes, Timothy P.
Publication type:
Article
Treatment-Free Remission After Second-Line Nilotinib Treatment in Patients With Chronic Myeloid Leukemia in Chronic Phase: Results From a Single-Group, Phase 2, Open-Label Study.
Published in:
2018
By:
- Mahon, François-Xavier;
- Boquimpani, Carla;
- Kim, Dong-Wook;
- Benyamini, Noam;
- Clementino, Nelma Cristina D;
- Shuvaev, Vasily;
- Ailawadhi, Sikander;
- Lipton, Jeffrey Howard;
- Turkina, Anna G;
- De Paz, Raquel;
- Moiraghi, Beatriz;
- Nicolini, Franck E;
- Dengler, Jolanta;
- Sacha, Tomasz;
- Takahashi, Naoto;
- Fellague-Chebra, Rafik;
- Acharya, Sandip;
- Wong, Stephane;
- Jin, Yu;
- Hughes, Timothy P
Publication type:
journal article

Found: 17